Karyopharm Therapeutics Inc. (KPTI) Insider Trading

Over the last 3 months, KPTI insiders made 0 open-market buys and 7 sales, a net sale of -$39K (SEC Form 4). Over the last 6 months, 52 institutions increased and 14 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$38.8K
Insider trades by month Buys Sells
Sep
Oct
Jan
Feb
Apr
May
Context3-month price -1.6%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 26, 2026Su ZhendirectorGrant15,508
May 26, 2026BOHLIN GAREN GdirectorGrant15,508
May 26, 2026Schor ChendirectorGrant15,508
May 26, 2026Greene Barry EdirectorGrant15,508
May 26, 2026PAKIANATHAN DEEPIKAdirectorGrant15,508
May 26, 2026Oliger Christy J.directorGrant15,508
May 15, 2026Mano Michaelofficer: EVP, CLO&SecretaryGrant700
May 15, 2026Abate Kristinofficer: Chief Accounting OfficerSell53$9.50
May 15, 2026Rangwala Reshmaofficer: EVP & Chief Medical OfficerSell408$9.50
May 15, 2026Abate Kristinofficer: Chief Accounting OfficerGrant121
May 15, 2026Rangwala Reshmaofficer: EVP & Chief Medical OfficerGrant947
May 15, 2026Poulton Stuartofficer: EVP, Chief Development OfficerSell403$9.50
May 15, 2026Poulton Stuartofficer: EVP, Chief Development OfficerGrant896
May 15, 2026Cheng Sohanya Roshanofficer: EVP & Chief Commercial OfficerGrant947
May 15, 2026Mano Michaelofficer: EVP, CLO&SecretarySell266$9.50
May 15, 2026Paulson Richard A.director, officer: President and CEOGrant4,920
May 15, 2026Cheng Sohanya Roshanofficer: EVP & Chief Commercial OfficerSell324$9.50
May 15, 2026Paulson Richard A.director, officer: President and CEOSell2,203$9.50
Apr 22, 2026Rangwala Reshmaofficer: EVP & Chief Medical OfficerSell449$8.94
Feb 19, 2026Poulton Stuartofficer: EVP, Chief Development OfficerSell378$8.63
Feb 9, 2026Paulson Richard A.director, officer: President and CEOGrant81,060
Feb 4, 2026Macomber Loriofficer: EVP, CFO & TreasurerSell1,626$6.30
Feb 3, 2026Mano Michaelofficer: EVP, CLO&SecretaryGrant32,415
Feb 3, 2026Macomber Loriofficer: EVP, CFO & TreasurerGrant32,415
Feb 3, 2026Cheng Sohanya Roshanofficer: EVP & Chief Commercial OfficerGrant32,415
Feb 3, 2026Poulton Stuartofficer: EVP, Chief Development OfficerGrant32,415
Feb 3, 2026Rangwala Reshmaofficer: EVP & Chief Medical OfficerGrant32,415
Jan 29, 2026Abate Kristinofficer: Chief Accounting OfficerSell50$7.03
Jan 29, 2026Abate Kristinofficer: Chief Accounting OfficerGrant92
Jan 22, 2026Abate Kristinofficer: Chief Accounting OfficerSell265$5.96

Source: KPTI SEC Form 4 filings, latest May 26, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their KPTI positions over the last 6 months (SEC Form 13F).

Increased
52
New positions
60
Reduced
14
Sold out
22
Largest moves
InstitutionActionSharesFiled
COMMODORE CAPITAL LPNew Position1.9MMay 15, 2026
RA CAPITAL MANAGEMENT, L.P.New Position1.9MMay 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased1.8MMay 15, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Increased1.5MMay 15, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Increased1.5MFeb 19, 2026
CAPTION MANAGEMENT, LLCNew Position1.1MMay 15, 2026
GOLDMAN SACHS GROUP INCIncreased948KMay 15, 2026
OPALEYE MANAGEMENT INC.New Position930KFeb 17, 2026
IKARIAN CAPITAL, LLCNew Position920KMay 15, 2026
CATALIO CAPITAL MANAGEMENT, LPIncreased898KMay 15, 2026
AFFINITY ASSET ADVISORS, LLCNew Position890KFeb 13, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased865KMay 15, 2026
Squadron Capital Management LLCNew Position750KMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position740KMay 15, 2026
VANGUARD GROUP INCIncreased560KJan 29, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.